Create a free account or log in.
At Sobi, we are transforming life for people with rare diseases. As an international biopharmaceutical company, we provide access to innovative treatments in the areas of haematology, immunology and specialty care.
- Two therapeutic areas – Haematology and Immunology – and a portfolio of products within Specialty Care
- Our extended half-life factor replacement treatments are the most prescribed treatments for haemophilia - A and B respectively in several markets
- A strong portfolio of on-market products, and an extensive portfolio of pre-market assets
- An international biopharmaceutical company covering the entire value chain
- We put our focus where we can have the greatest impact, in late-stage research and development, and in patient access and commercialisation
1,509
Worldwide
Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).
| Filing Information | Date & Language | Document Details | Actions |
|---|
No filings found matching your criteria
| Person (Position) | Type | Volume | Price | Date |
|---|---|---|---|---|
|
↓
Katy Mazibuko
(Other)
|
Sell | SEK 480,000.00 | SEK 320.00 | 30.08.24 |
|
↓
Katy Mazibuko
(Other)
|
Sell | SEK 86,012.75 | SEK 319.75 | 30.08.24 |
|
↑
Sara Karlsson
(Other)
|
Buy | SEK 23,391.79 | SEK 271.99 | 12.08.24 |
|
↑
Mahmood Ladha
(Other)
|
Buy | SEK 12,360,406.05 | SEK 146.13 | 25.07.24 |
|
↓
Mahmood Ladha
(Other)
|
Sell | SEK 24,614,235.00 | SEK 291.00 | 23.07.24 |
|
◆
Christin Wesström
(Other)
|
Other | SEK 0.00 | SEK 0.00 | 10.06.24 |
|
↑
Guido Oelkers
(Other)
|
Buy | SEK 23,965,061.00 | SEK 204.25 | 03.06.24 |
|
↓
Guido Oelkers
(Other)
|
Sell | SEK 32,090,302.00 | SEK 273.50 | 30.05.24 |
|
↑
Henrik Stenqvist
(Other)
|
Buy | SEK 14,815,069.50 | SEK 204.25 | 15.05.24 |
|
↓
Henrik Stenqvist
(Other)
|
Sell | SEK 20,766,484.20 | SEK 286.30 | 13.05.24 |
549300124Y3MQI87PT35
IKM
Sector
Health Care
Country
Spain
ISIN
Founded
1NKEMIA specializes in biotechnology research and innovation, offering advanced solutions for the pharmaceutical, chemical, and energy sectors.
2CUREX
Sector
Health Care
Country
Sweden
ISIN
SE0010468124
Founded
2cureX AB is a Danish biotech company specializing in functional precision medicine. It develops diagnostic tools to personalize cancer treatment.
VSC
Sector
Health Care
Country
Germany
ISIN
DE000A3E5C40
Founded
1997
4SC focuses on the development of novel small molecule drugs that target key mechanisms of cancer development, such as histone …
ABERA
Sector
Health Care
Country
Sweden
ISIN
SE0015245097
Founded
Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed …
ABNX
Sector
Health Care
Country
France
ISIN
FR0012616852
Founded
ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there …
ABLI
Sector
Health Care
Country
Sweden
ISIN
SE0002575340
Founded
2000
Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when …